by Keishi Foecke | Aug 6, 2025 | Innovations Advanced by M&A
This blog is another installment in a series, Innovations Advanced by M&A, that underscores the unique role of mergers and acquisitions in promoting a competitive and innovative life sciences ecosystem for patients. You can find previous blogs in this...
by Keishi Foecke | Jul 30, 2025 | Blog Post
The Federal Trade Commission (FTC) and Department of Justice (DOJ)’s approach toward mergers and acquisitions (M&A) is obstructing a critical exit point for innovative early-stage companies, according to Vanderbilt University Law School professor Brian Broughman...
by Keishi Foecke | Jul 23, 2025 | PULSE Partner
In a recent op-ed for Deseret News, Kelvyn Cullimore, CEO of PULSE Partner BioUtah, emphasizes the importance of federal policies that support pro-competitive life sciences mergers and acquisitions (M&A), in order to sustain innovation and growth in the life...
by Keishi Foecke | Jul 16, 2025 | Blog Post
Over the last several months, PULSE and its network of nearly 40 partners have continued to build awareness of the unique and fundamental role of life sciences mergers and acquisitions (M&A). Read below for a round-up of recent PULSE updates and commentaries....
by Keishi Foecke | Jun 26, 2025 | Blog Post, Innovations Advanced by M&A
This blog is another installment in a series, Innovations Advanced by M&A, that underscores the unique role of mergers and acquisitions in promoting a competitive and innovation life sciences ecosystem for patients. You can find previous blogs in this series here....
by Keishi Foecke | Jun 18, 2025 | Blog Post
As small and mid-sized biotech companies are facing increasing funding pressures, life sciences mergers and acquisitions (M&A) have emerged as an increasingly important mechanism to sustain innovation and advance new therapies. A recent analyst note highlighted...
